Global Brain Tumor Diagnostics Market 2022-2026
Technavio has been monitoring the brain tumor diagnostics market and it is poised to grow by $ 177.66 mn during 2022-2026, progressing at a CAGR of 3.89% during the forecast period. Our report on the brain tumor diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of brain cancer and high morbidity of brain tumors. In addition, the increasing prevalence of brain cancer is anticipated to boost the growth of the market as well.
The brain tumor diagnostics market analysis includes the type segment and geographic landscape.
Technavio's brain tumor diagnostics market is segmented as below:
By Type
- Imaging test
- Biopsy
- Molecular testing
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the growing importance of tele-imagingas one of the prime reasons driving the brain tumor diagnostics market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on brain tumor diagnostics market covers the following areas:
- Brain tumor diagnostics market sizing
- Brain tumor diagnostics market forecast
- Brain tumor diagnostics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading brain tumor diagnostics market vendors that include Canon Inc., FUJIFILM Holdings Corp., General Electric Co., Hitachi Ltd., Hologic Inc., Koninklijke Philips NV, MDxHealth Group, Neusoft Medical Systems Co. Ltd., Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Also, the brain tumor diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Companies MentionedCanon Inc., FUJIFILM Holdings Corp., General Electric Co., Hitachi Ltd., Hologic Inc., Koninklijke Philips NV, MDxHealth Group, Neusoft Medical Systems Co. Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc.